Instrument Inactif

Communiqués Albany Molecular Research, Inc.

Actions

US0124231095

Recherche biotechnologique et médicale

Communiqués

17/01/18	Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	PU
04/01/18	Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	PU
19/12/17	Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	PU
30/11/17	Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	PU
09/11/17	Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	PU
02/11/17	Albany Molecular Research : AMRI to Exhibit and Present at MD&M Minneapolis 2017	PU
31/10/17	Albany Molecular Research : AMRI Appoints Paul Feuerman as Senior Vice President General Counsel and Head of Busine...	PU
25/10/17	Robbins Geller Rudman & Dowd LLP : Files Class Action Suit against Albany Molecular Research, Inc.	BU
23/10/17	Albany Molecular Research : AMRI to Highlight Sterile Manufacturing Capacity Expansion, New Technologies at CPhI	PU
12/10/17	Albany Molecular Research : AMRI Launches Stand-Alone Service; Expanding Solutions for Impurity Analysis and Toxico...	PU
02/10/17	Albany Molecular Research : AMRI Names Joseph D. Sangregorio as Senior Vice President and Chief Human Resources Off...	PU
21/09/17	Albany Molecular Research : AMRI Assembles a Comprehensive Medical Device Expert Solutions Team	PU
13/09/17	Albany Molecular Research : AMRI’s John Iannone Named US Expert to ISO Technical Committee	PU
12/09/17	3ST Research : Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Research Inc. (AMRI)	PR
14/06/17	Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information	BU
13/06/17	The Law Offices of Vincent Wong : Reminds Investors of an Investigation of Albany Molecular Research, Inc. in Connection with the Sale of the Company to GTCR LLC and The Carlyle Group	BU
09/06/17	The Law Offices of Vincent Wong : Notifies Investors of an Investigation of Albany Molecular Research, Inc. in Connection with the Sale of the Company to GTCR LLC and The Carlyle Group	BU
09/06/17	WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders	PR
07/06/17	Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information	BU
07/06/17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Albany Molecular Research, Inc. to The Carlyle Group and GTCR LLC is Fair to Shareholders	BU
07/06/17	Albany Molecular Research : Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular Research	PR
07/06/17	ALBANY MOLECULAR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albany Molecular Research, Inc.	PR
06/06/17	Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Albany Molecular Research, Inc. to The Carlyle Group and GTCR LLC is Fair to Shareholders	BU
06/06/17	ALBANY MOLECULAR RESEARCH, INC. Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
06/06/17	Albany Molecular (AMRI) Alert: J&W Investigates Price and Process of Proposed Sale of Albany Molecular Research, Inc.; Is $21.75 a Fair Price?	PR